111. Deputy David Cullinane asked the Minister for Health if Brexit has had or will have implications on the supply and use of products approved for use under the medical cannabis access programme considering that products approved for use on the programme must be sold or supplied for medical purposes by the relevant public or state body of a member state other than the state and must be currently supplied to patients in the member state as outlined in the legislation; and if he will make a statement on the matter. [22377/21]

Summary

111. Deputy David Cullinane asked the Minister for Health if Brexit has had or will have implications on the supply and use of products approved for use under the medical cannabis access programme considering that products approved for use on the programme must be sold or supplied for medical purposes by the relevant public or state body of a member state other than the state and must be currently supplied to patients in the member state as outlined in the legislation; and if he will make a statement on the matter. [22377/21]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Cannabis for Medicinal Use

  xml · EN · 29 April 2021

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.